Sivik Global Healthcare LLC - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 190 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.

Quarter-by-quarter ownership
Sivik Global Healthcare LLC ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$1,440,000
+7.7%
40,000
-20.0%
0.73%
+125.1%
Q2 2019$1,337,000
+84.9%
50,000
+5.6%
0.32%
+16.2%
Q2 2018$723,000
-63.1%
47,351
-27.2%
0.28%
-61.7%
Q4 2017$1,957,000
-56.7%
65,000
-45.8%
0.73%
-52.8%
Q3 2017$4,520,000
+194.7%
120,000
+118.2%
1.54%
+174.2%
Q2 2017$1,534,000
-31.4%
55,000
-15.4%
0.56%
-46.1%
Q1 2017$2,235,000
+10.7%
65,000
-7.1%
1.04%
+8.1%
Q4 2016$2,019,000
-3.2%
70,000
+6.7%
0.96%
-8.5%
Q3 2016$2,086,000
+11.8%
65,577
+14.0%
1.05%
+13.4%
Q2 2016$1,866,000
-33.3%
57,500
-42.5%
0.93%
-25.0%
Q1 2016$2,796,000
+30.7%
100,000
+66.7%
1.24%
+21.9%
Q4 2015$2,139,000
+14.9%
60,000
+6.5%
1.02%
+12.5%
Q3 2015$1,862,000
-11.1%
56,314
+12.6%
0.90%
+24.2%
Q2 2015$2,094,000
+83.5%
50,000
+42.9%
0.73%
+87.4%
Q1 2015$1,141,00035,0000.39%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
March Altus Capital Management LP 82,723$2,685,00020.75%
HWG Holdings LP 289,380$9,393,0008.72%
Baker Brothers Advisors 24,516,738$795,813,0008.34%
HARVEY CAPITAL MANAGEMENT INC 352,200$11,432,0005.73%
Belmont Global Advisors, Inc. 150,000$4,869,0004.67%
Palo Alto Investors LP 1,437,730$46,669,0003.52%
Avoro Capital Advisors LLC 329,500$10,696,0002.38%
GARRISON BRADFORD & ASSOCIATES INC 70,100$2,275,0002.23%
WEATHERBIE CAPITAL, LLC 401,642$13,037,0001.85%
ACUTA CAPITAL PARTNERS, LLC 85,999$2,792,0001.34%
View complete list of ACADIA PHARMACEUTICALS INC shareholders